|
Volumn 51, Issue 98, 2015, Pages 17435-17438
|
The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARGINYLGLYCYLASPARTIC ACID;
CATHEPSIN B;
ENZYME;
GEMCITABINE;
GLUTATHIONE;
PRODRUG;
TETRAPHENYLENE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
BUTHIONINE SULFOXIMINE;
CYSTEINE PROTEINASE INHIBITOR;
DEOXYCYTIDINE;
DIPEPTIDE;
FLUORESCENT DYE;
N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE;
S-ETHYL GLUTATHIONE;
VITRONECTIN RECEPTOR;
AMINO ACID SEQUENCE;
ARTICLE;
CANCER INHIBITION;
CANCER THERAPY;
CELL VIABILITY;
DISULFIDE BOND;
DRUG DESIGN;
FLUORESCENT LIGHTING;
HYDROPHILICITY;
INTERNALIZATION;
PANCREAS CANCER;
ANALOGS AND DERIVATIVES;
ANTAGONISTS AND INHIBITORS;
CHEMISTRY;
ENDOCYTOSIS;
HUMAN;
METABOLISM;
OXIDATION REDUCTION REACTION;
PANCREATIC NEOPLASMS;
PHYSIOLOGY;
SYNTHESIS;
TUMOR CELL LINE;
AMINO ACID SEQUENCE;
ANTINEOPLASTIC AGENTS;
BUTHIONINE SULFOXIMINE;
CATHEPSIN B;
CELL LINE, TUMOR;
CYSTEINE PROTEINASE INHIBITORS;
DEOXYCYTIDINE;
DIPEPTIDES;
ENDOCYTOSIS;
FLUORESCENT DYES;
GLUTATHIONE;
HUMANS;
INTEGRIN ALPHAVBETA3;
OXIDATION-REDUCTION;
PANCREATIC NEOPLASMS;
PRODRUGS;
|
EID: 84948798631
PISSN: 13597345
EISSN: 1364548X
Source Type: Journal
DOI: 10.1039/c5cc06654a Document Type: Article |
Times cited : (63)
|
References (44)
|